Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Young Adults With Inflammatory Bowel Disease Receiving Biologics.
作者信息
Bellusci Lorenza, Zahra Fatema Tuz, Hopkins Dena E, Salazar Juan C, Hyams Jeffrey S, Khurana Surender
机构信息
Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut; School of Medicine, University of Connecticut, Farmington, Connecticut.
出版信息
Gastroenterology. 2022 Dec;163(6):1672-1675. doi: 10.1053/j.gastro.2022.08.009. Epub 2022 Aug 10.
Abstract
摘要
Zotero 插件